Literature DB >> 11904200

Giant prolactinomas presenting as skull base tumors.

Giuseppe Minniti1, Marie Lise Jaffrain-Rea, Antonio Santoro, Vincenzo Esposito, Luigi Ferrante, Roberto Delfini, Giampaolo Cantore.   

Abstract

BACKGROUND: Prolactinomas invading the skull base are rare, and could easily be confused with skull base tumors of nonpituitary origin. CASE DESCRIPTION: We report a series of 4 cases of giant prolactinomas invading the skull base and presenting with atypical symptoms. Case 1 presented with a short history of headache and nasal obstruction. Case 2 presented with progressive hypoacusia, dizziness, and ophthalmoplegia. In Case 3, the patient developed rapid progressive visual failure and psychiatric symptoms. Case 4 presented with a 1-year history of headache and retrorbital pain. The diagnosis of prolactinoma was made on the basis of tumor immunohistochemistry and/or high plasma prolactin levels (range from 650-6,500 ng/mL). Medical treatment with the dopamine agonist cabergoline was given; it was effective in normalizing prolactin levels and inducing tumor shrinkage.
CONCLUSION: Prolactin levels should be measured in all large skull base tumors involving the pituitary region before any surgery or inappropriate radiotherapy is performed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904200     DOI: 10.1016/s0090-3019(01)00697-8

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  9 in total

1.  Combined treatment of invasive giant prolactinomas.

Authors:  Chonjiang Yu; Zhebao Wu; Jian Gong
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

2.  Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men.

Authors:  Arijit Chattopadhyay; Anil Bhansali; Shariq R Masoodi
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

3.  [Female patient with depressive psychosis and visual disturbances].

Authors:  M Neubacher; M Reuter; K Hauenstein
Journal:  Radiologe       Date:  2013-08       Impact factor: 0.635

4.  Giant prolactinomas: clinical manifestations and outcomes of 16 Arab cases.

Authors:  Mussa H Almalki; Badurudeen Buhary; Saad Alzahrani; Fahad Alshahrani; Safia Alsherbeni; Ghada Alhowsawi; Naji Aljohani
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

5.  A giant prolactinoma with nasopharyngeal extension presenting with nasal blockage and epistaxis.

Authors:  Jaya Prakash Sahoo; Sadishkumar Kamalanathan; Pradipta Kumar Parida; Vivekanandan Pillai
Journal:  BMJ Case Rep       Date:  2015-04-29

Review 6.  Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas.

Authors:  Ricardo J Komotar; Robert M Starke; Daniel M S Raper; Vijay K Anand; Theodore H Schwartz
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

7.  Long-term outcome of multimodal therapy for giant prolactinomas.

Authors:  Paula Andujar-Plata; Rocio Villar-Taibo; Maria Dolores Ballesteros-Pomar; Alfonso Vidal-Casariego; Begoña Pérez-Corral; Jose Manuel Cabezas-Agrícola; Paula Álvarez-Vázquez; Ramón Serramito; Ignacio Bernabeu
Journal:  Endocrine       Date:  2016-10-04       Impact factor: 3.633

8.  Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population.

Authors:  Farida Chentli; Said Azzoug; Katia Daffeur; Lina Akkache; Hadjer Zellagui; Meriem Haddad; Nadia Kalafate
Journal:  Indian J Endocrinol Metab       Date:  2015 May-Jun

9.  Giant Prolactinoma Presenting With Facial Nerve Palsy and Hemiparesis.

Authors:  Aleksandra Sliwinska; Fatima Jalil; Lori De La Portilla; Michael Baldwin; Joseph Lorenzo; Ketan R Bulsara; Faryal S Mirza
Journal:  J Endocr Soc       Date:  2021-04-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.